LA
CO

Lucus Advisors’s Global Cord Blood Corporation CO Stock Holding History

Lucus Advisors’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$160K Sell
15,717
-17,757
-53% -$181K 0.28% 187
2017
Q4 		$333K Buy
33,474
+939
+3% +$10.3K 0.49% 111
2017
Q3 		$362K Sell
32,535
-5,975
-16% -$69.9K 0.51% 9
2017
Q2 		$365K Buy
+38,510
New +$307K 0.49% 18

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SAM
Silphium Asset Management London, United Kingdom $297M AUM 28.02% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lucus Advisors's CO Position: Q1 2018 in Review

Lucus Advisors reduced its Global Cord Blood Corporation (CO) stake by 53% in Q1 2018, selling an estimated $181K and leaving 15,717 shares worth $160K. The position accounts for 0.28% of the portfolio, ranked #187.

Lucus Advisors first reported a position in CO in Q2 2017 and has held it in 4 quarters since. The position peaked at $365K in Q2 2017. 58 funds tracked by Wall St. Rank hold CO as of Q1 2018.

  • Lucus Advisors held 15,717 shares of Global Cord Blood Corporation worth $160K as of Q1 2018.
  • Lucus Advisors sold 17,757 Global Cord Blood Corporation shares in Q1 2018, an estimated $181K.
  • Global Cord Blood Corporation made up 0.28% of Lucus Advisors's portfolio in Q1 2018, its #187 holding.
  • Lucus Advisors first reported a position in Global Cord Blood Corporation in Q2 2017 and has held it in 4 quarters since.
  • Lucus Advisors's Global Cord Blood Corporation position peaked at $365K in Q2 2017.
  • 58 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2018.

Based on Lucus Advisors's 13F filing for Q1 2018, filed 15 May 2018.